文献速递病毒性肝炎

西非冈比亚隐匿性乙肝感染的患病率与临床意义

Prevalence and Clinical Significance of Occult Hepatitis B Infection in The Gambia, West Africa.
PubMed 文献 · J Infect Dis · 2022-01-01

基于PROLIFICA队列,比较HBsAg阴性普通人群对照与HBsAg阴性晚期肝病患者的OBI患病率,并估算OBI对晚期肝病的人群归因分数。结果显示病例组OBI患病率显著高于对照组,OBI为晚期肝病独立危险因素,建议HBsAg阴性肝病患者系统筛查OBI。

要点

  • HBsAg阴性晚期肝病患者OBI患病率18.3%,显著高于对照的9.4%。
  • 调整年龄、性别和抗HCV后,OBI与晚期肝病独立相关(OR 2.8)。
  • HBsAg阴性人群中,OBI对晚期肝病的人群归因分数为12.9%。

核心结论

  • OBI在西非冈比亚呈地方性流行,且为晚期肝病的独立危险因素。
  • HBsAg阴性肝病患者应系统筛查OBI。
  • 婴儿乙肝免疫预防对终末期肝病的实际影响可能高于仅基于HBsAg阳性的既往估计。

研究设计与样本

  • 基于PROLIFICA队列,比较HBsAg阴性普通人群对照与HBsAg阴性晚期肝病患者的OBI患病率。

主要发现

  • 病例组OBI患病率为18.3%(15/82),对照组为9.4%(31/330),差异有统计学意义(P = .03)。
  • 调整年龄、性别和抗HCV血清学后,OBI与晚期肝病显著相关(OR 2.8;95%CI 1.3-6.0;P = .006)。
  • HBsAg阴性人群中,归因于OBI和HCV的晚期肝病比例分别为12.9%(95%CI 7.5%-18.1%)和16.9%(95%CI 15.2%-18.6%)。

关键数值与推荐

  • OBI在病例组患病率18.3%(15/82),对照组9.4%(31/330),P = .03。
  • OBI与晚期肝病的调整OR为2.8(95%CI 1.3-6.0,P = .006)。
  • OBI的人群归因分数为12.9%(95%CI 7.5%-18.1%)。

临床怎么用

  • 对HBsAg阴性但存在晚期肝病的患者,应考虑系统筛查OBI。
  • 评估乙肝免疫预防对终末期肝病的长期影响时,需考虑OBI的贡献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prevalence and clinical outcomes of occult hepatitis B infection (OBI) have been poorly studied in Africa. METHODS: Using the PROLIFICA cohort, we compared the prevalence of OBI between hepatitis B surface antigen (HBsAg)-negative healthy adults screened from the general population (controls) and HBsAg-negative patients with advanced liver disease (cases), and estimated the population attributable fraction for the effect of OBI on advanced liver disease. RESULTS: OBI prevalence was significantly higher among cases (15/82, 18.3%) than controls (31/330, 9.4%, P = .03). After adjusting for age, sex, and anti-hepatitis C virus (HCV) serology, OBI was significantly associated with advanced liver disease (odds ratio, 2.8; 95% confidence interval [CI], 1.3-6.0; P = .006). In HBsAg-negative people, the proportions of advanced liver disease cases attributable to OBI and HCV were estimated at 12.9% (95% CI, 7.5%-18.1%) and 16.9% (95% CI, 15.2%-18.6%), respectively. CONCLUSIONS: OBI is endemic and an independent risk factor for advanced liver disease in The Gambia, West Africa. This implies that HBsAg-negative people with liver disease should be systematically screened for OBI. Moreover, the impact of infant hepatitis B immunization to prevent end-stage liver disease might be higher than previous estimates based solely on HBsAg positivity.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ndow G, Cessay A, Cohen D, et al. Prevalence and Clinical Significance of Occult Hepatitis B Infection in The Gambia, West Africa. J Infect Dis. 2022. PMID: 34160616. doi:10.1093/infdis/jiab327

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。